epirubicin has been researched along with Adenocarcinoma Of Kidney in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartnik, E; Bielecka, ZF; Brodaczewska, KK; Czarnecka, AM; Maliszewska-Olejniczak, K; Porta, C; Szczylik, C | 1 |
Inui, M; Jin, C; Jin, X; Kakehi, Y; Sugimoto, M; Wu, XX | 1 |
Kakehi, Y; Ogawa, O; Wu, XX | 1 |
Gao, XK; Kang, FX; Li, Q; Shao, GX; Wang, H; Yang, B; Yuan, JL | 1 |
Arai, Y; Kakehi, Y; Kanba, T; Shichiri, Y; Yoshida, O; Yoshida, S | 1 |
Casadio, M; Guaraldi, M; Lelli, G; Martoni, A; Panetta, A; Pannuti, F; Tamberi, S | 1 |
Senft, M; Strnad, V | 1 |
Hasegawa, S; Kikuchi, E; Miyakita, M; Shimizu, K; Tanomogi, H; Yamataka, K | 1 |
Kakehi, Y; Mizutani, Y; Ogawa, O; Wu, XX; Yoshida, O | 1 |
Cersosimo, RJ; Hong, WK | 1 |
1 review(s) available for epirubicin and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Topics: Bone Marrow; Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Heart; Humans; Kidney Neoplasms; Kinetics; Leukemia; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms | 1986 |
9 other study(ies) available for epirubicin and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance.
Topics: Biomarkers, Tumor; Biomimetics; Carcinoma, Renal Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Culture Media, Serum-Free; Doxycycline; Drug Resistance, Neoplasm; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Laminin; Neoplasm Metastasis; Neoplastic Stem Cells; Phenotype; Spheroids, Cellular; Sunitinib | 2019 |
Delineation of apoptotic genes for synergistic apoptosis of lexatumumab and anthracyclines in human renal cell carcinoma cells by polymerase chain reaction array.
Topics: Anthracyclines; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Caspases; Cell Line, Tumor; Doxorubicin; Drug Synergism; Epirubicin; Humans; Kidney Neoplasms; Polymerase Chain Reaction; Receptors, TNF-Related Apoptosis-Inducing Ligand | 2012 |
Sensitization of human renal cell carcinoma cell lines to TRAIL-induced apoptosis by anthracyclines.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Renal Cell; Cell Line, Tumor; Epirubicin; Humans; Kidney Neoplasms; Membrane Glycoproteins; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha | 2004 |
[Antisense oligonucleotide targeting survivin induces apoptosis of renal clear-cell carcinoma cells and enhances their sensitivity to epirubicin in vitro].
Topics: Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Epirubicin; Humans; Inhibitor of Apoptosis Proteins; Kidney Neoplasms; Microtubule-Associated Proteins; Neoplasm Proteins; Oligonucleotides, Antisense; Survivin; Transfection | 2005 |
Intra-arterial infusion chemotherapy in combination with a biscoclaurine alkaloid, Cepharanthin, to treat bone metastasis arising from renal cell carcinoma.
Topics: Alkaloids; Angiography; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Biopsy; Bone Neoplasms; Carcinoma, Renal Cell; Epirubicin; Humans; Ilium; Injections, Intra-Arterial; Kidney Neoplasms; Male; Middle Aged; Recurrence; Tomography, X-Ray Computed; Vinblastine | 1994 |
Combined chemo-immuno-hormonotherapy of advanced renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Kidney Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Recombinant Proteins; Survival Rate; Vinblastine | 1994 |
[Radiochemotherapy in the treatment of metastatic renal cell carcinoma].
Topics: Aged; Carcinoma, Renal Cell; Combined Modality Therapy; Epirubicin; Humans; Kidney Neoplasms; Male | 1993 |
[A case of surgical resection for metachronous multiple liver metastases of chromophobe cell renal carcinoma].
Topics: Carcinoma, Renal Cell; Embolization, Therapeutic; Epirubicin; Female; Hepatectomy; Humans; Iodized Oil; Kidney Neoplasms; Liver Neoplasms; Middle Aged | 1998 |
Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
Topics: Acridine Orange; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Carcinoma, Renal Cell; Caspase 3; Caspases; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Epirubicin; fas Receptor; Fluorescent Dyes; Fluorouracil; Humans; Immunohistochemistry; Interferon-alpha; Interferon-gamma; Kidney Neoplasms; Lymphocytes, Tumor-Infiltrating; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vinblastine | 2000 |